Octacillin 697 mg/g Powder for Use in Drinking Water for Pigs
Amoxicillin
Last verified
Veterinary medicinal product: powder for use in drinking water. Distribution category: POM-V (Veterinary Medicines Regulations 2013, Schedule 3). Active substance: Amoxicillin.1
In short: questions and answers
- Does Octacillin 697 mg/g Powder for Use in Drinking Water for Pigs need a prescription?
- Prescription only. As stated in the registration decision.1
- Which animals is Octacillin 697 mg/g Powder for Use in Drinking Water for Pigs for?
- Pigs.1
- What is the active substance in Octacillin 697 mg/g Powder for Use in Drinking Water for Pigs?
- Amoxicillin. ATCvet code: QJ01CA04.13
- What is the withdrawal period of Octacillin 697 mg/g Powder for Use in Drinking Water for Pigs according to the leaflet?
- Pigs, meat: 2 days.3
- Dispensing
- Prescription only1
POM-V: Prescription Only Medicine - Veterinarian. Supplied only on a prescription written by a veterinary surgeon who has assessed the animal.12
Supplied only on a veterinarian's prescription. As stated in the registration decision.
- Animal species
- Pigs1
- Active substance
- Amoxicillin
- ATCvet code
- QJ01CA043
- Manufacturer
- Marketing authorisation holder: Eurovet Animal Health B.V.
Withdrawal period
| Animal species | Product | days |
|---|---|---|
| Pigs | meat | 23 |
Summary of product characteristics
Composition
Each gram contains:
Active substance:
Amoxicillin 697 mg equivalent to amoxicillin trihydrate 800 mg
Excipients:
White to pale yellow-white powder.
| Qualitative composition of excipients and other constituents |
|---|
| Sodium carbonate monohydrate |
| Sodium citrate |
| Colloidal anhydrous silica |
Pharmacological properties
4.1 ATCvet code:
QJ01CA04.
4.2 Pharmacodynamics
The active ingredient, amoxicillin, is a bactericidal, mainly time-dependant antibiotic of the betalactam class. It acts by inhibition of bacterial cell wall synthesis. Amoxicillin has a bactericidal effect on a wide range of Gram-positive and Gram-negative bacteria. The MIC50/MIC90 of Actinobacillus pleuropneumoniae is 0.25μ g/ml. The MIC50/MIC90 of Streptococcus suis is ≤ 0.03 μ g/ml.
In general, practical development of resistance in vitro against amoxicillin like all penicillins occurs slowly and stepwise, with an existing cross-resistance with other penicillins which is of practical significance in staphylococcus infections. Both long term treatment and sub-therapeutic dosages can select for antimicrobial resistance. Resistance to ß-lactam antibiotics is essentially linked to ß-lactamases which hydrolyse them.
4.3 Pharmacokinetics
With this veterinary medicinal product high amoxicillin concentrations are quickly reached in the blood. After oral administration, amoxicillin is largely absorbed (74 - 92 %). This antibiotic is well distributed to all organs and tissues, where also high concentrations are reached. Amoxicillin is largely excreted by the kidneys in the unchanged form. A smaller part of the administered dose of amoxicillin is excreted in the bile and also in the milk.
Target species
Pigs.
Indications
Treatment of infections caused by bacteria sensitive to amoxicillin:
Pigs: Pleuropneumonia caused by Actinobacillus pleuropneumoniae, Meningitis caused by Streptococcus suis
Dosage
In drinking water use.
Pigs:
The recommended daily dose is 16 mg amoxicillin trihydrate - corresponding to 14 mg amoxicillin per kg of body weight, i.e. 20 mg of the veterinary medicinal product per kg of body weight equivalent to 1 gram veterinary medicinal product per 50 kg body weight per day, given for 3-5 consecutive days. In case of severe infections the medication period must be prolonged to 5 days as determined by the attending veterinary surgeon.
Bolus dosage: It is recommended to administer the veterinary medicinal product once a day for a limited period of time. Shut off the drinking water system for approx. two hours (shorter time in warm weather) until the time of medication. Sprinkle the calculated daily quantity of powder on the surface of 5-10 litres water. Mix thoroughly until the powder has dissolved. Mix this solution by stirring into the volume of drinking water that will be drunk within about 2-3 hours.
Continuous treatment: The table below shows the guidelines for administering the veterinary medicinal product, assuming consumption of 100 litres drinking water a day based on a estimated water consumption of 1 litre per 10 kg of body weight in pigs under 4 months and 0.66 litre per 10 kg of body weight in pigs over 4 months.
| Pigs under 4 months: | 20 g powder/100 litres/day |
|---|---|
| Pigs over 4 months: | 30 g powder/100 litres/day |
In the case of continuous treatment, the medicated water must be changed twice daily.
Based on the recommended dose and the number and weight of animals to be treated, the exact daily concentration of the veterinary medicinal product should be calculated according to the following formula:
20 mg veterinary medicinal product / kg body weight day x average body weight (kg) of animals to be treated, divided by average daily water intake (l/animal)*, = mg veterinary medicinal product per litre of drinking water
* Prepare an amount of medicated water to be consumed within the next 12 hours. Any unused medicated water should be discarded after 12 hours, and fresh medicated water - for the next 12 hours - should be prepared
To ensure a correct dosage, body weight should be determined as accurately as possible.
The intake of medicated water depends on the clinical condition of the animals. In case of insufficient uptake of water, pigs should be treated parenterally. In order to obtain the correct dosage the concentration of amoxicillin has to be adjusted accordingly. The maximum concentration of the pre-diluted medicated water is approximately 8 grams of veterinary medicinal product per liters. The setting of the dosing device should be changed accordingly.
Make sure the animals do not have access to non-medicated water during the period when the medicated water is given. Once all the medicated water has been drunk, turn the drinking water system back on. Discard any excess medicated water after 12 hours. The use of suitably calibrated measuring equipment is recommended.
Contraindications
Do not use in cases of hypersensitivity to penicillin and other substances of the ß-lactam group or to any of the excipients.
Do not use in rabbits and rodents such as guinea pig, hamster or gerbil.
Do not use in animals with serious kidney malfunction including anuria and oliguria.
Adverse reactions
Pigs:
| Frequency | Adverse events |
|---|---|
| Undetermined frequency (cannot be estimated from the available data) | Hypersensitivity reaction* (e.g. skin rash, anaphylactic shock) |
*Varying in severity. If suspected adverse reactions occur, treatment should be discontinued.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Warnings
Special precautions for safe use in the target species:
Use of the veterinary medicinal product should be in accordance with official, national and regional antimicrobial policies. Use of the veterinary medicinal product should be based on identification and susceptibility testing of the target pathogen(s). If this is not possible, therapy should be based on epidemiological information and knowledge of susceptibility of the target pathogens at farm level, or at local/regional level. Use of the veterinary medicinal product deviating from the instructions given in the SPC may increase the prevalence of bacterial resistance to amoxicillin and may decrease its effectiveness of treatment with amoxicillin, due to the potential for cross-resistance.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross sensitivity to cephalosporins and vice versa. Allergic reactions to these substances may occasionally be serious.
Do not handle this veterinary medicinal product if you know you are sensitised or if you have been advised not to work with such preparations.
Handle this veterinary medicinal product with care to avoid exposure, taking all recommended precautions. Do not smoke, eat or drink while handling the veterinary medicinal product. During preparation and administration of the medicated drinking water, skin contact with the veterinary medicinal product and inhalation of dust particles should be avoided. Wear gloves and an appropriate dust mask when applying the veterinary medicinal product. Wash hands and contaminated skin immediately after handling the veterinary medicinal product.
In the event of eye or skin contact, rinse the affected area with large amounts of clean water and if irritation occurs, seek medical attention.
If you develop symptoms following exposure such as skin rash, you should seek medical advice and show this warning to the physician. Swelling of the face, lips or eyes, or difficulty with breathing are more serious symptoms and require urgent medical attention.
Special precautions for the protection of the environment:
Not applicable.
3.11 Special restrictions for use and special conditions for use, including restrictions on the use of antimicrobial and antiparasitic veterinary medicinal products in order to limit the risk of development of resistance
Not applicable.
Use during pregnancy, lactation or lay
The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
Pregnancy and lactation:
Use only according to the benefit-risk assessment by the responsible veterinarian. Laboratory studies in rats and rabbits have not produced any evidence of teratogenic, embryotoxic or maternotoxic effect of amoxicillin.
Interactions
The bactericidal effect of amoxicillin is counteracted by pharmaceuticals with a bacteriostatic effect.
Overdose
None known.
Special warnings
None.
Withdrawal period
Meat and offal: 2 days.
Incompatibilities
In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.
Immediate packaging
Multilayer sachets with pack sizes of 100 g, 250 g, 500 g or 1 kg. The sachets consist of the following materials: on the outside a white layer, inside different transparent layers, a sub-layer of aluminium and an inner layer of polyethylene.
Multilayer sachets with pack sizes of 100 g, 250 g, 500 g or 1 kg. The sachets consist of the following materials: on the outside a polyester layer, inside layers of aluminium and polyamide and an inner layer of polyethylene.
Not all pack sizes may be marketed.
Storage
This veterinary medicinal product as packaged for sale does not require any special storage conditions.
After opening/reconstitution:
Do not store above 25ºC.
Keep the bag tightly closed in order to protect from moisture.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 3 years.
Shelf life after first opening the immediate packaging: 1 month.
Shelf life after dilution or reconstitution according to directions: 12 hours.
Disposal of unused product
Medicines should not be disposed of via wastewater or household waste.
Use take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived thereof in accordance with local requirements and with any national collection systems applicable to the veterinary medicinal product concerned.
Additional information
Vm 16849/4030
8 DATE OF FIRST AUTHORISATION
20 December 2010
9 DATE OF THE LAST REVISION OF THE SUMMARY OF THE PRODUCT CHARACTERISTICS
January 2025
10 CLASSIFICATION OF VETERINARY MEDICINAL PRODUCT
Veterinary medicinal product subject to prescription.
Find more product information by searching for the ‘Product Information Database’ on www.gov.uk.
Approved: 24 April 2025
Registration holder
Eurovet Animal Health B.V.
Regulations
- Veterinary Medicines Regulations 2013 (SI 2013/2033), Schedule 32
Sources
- VMD Product Information Database: Octacillin 697 mg/g Powder for Use in Drinking Water for Pigs, 16849/4030
- The Veterinary Medicines Regulations 2013, Schedule 3 (categories of veterinary medicinal products)
- Summary of Product Characteristics: Octacillin 697 mg/g Powder for Use in Drinking Water for Pigs
Other products with the same active substance
- Amoxibactin 250 mg Tablets for Dogs
- Amoxibactin 50 mg Tablets for Dogs and Cats
- Amoxibactin 500 mg Tablets for Dogs
- Betamox Palatable Drops Powder for Oral Suspension 50 mg/ml
- Perlium Amoxival 100 mg/g Premix for Medicated Feeding Stuff for Pigs
- Stabox 50 mg/g premix for medicated feeding stuff for pigs
- Stabox 50% w/w Powder for Oral Solution for Pigs
- Vetrimoxin 50 mg/g Premix for Medicated Feeding Stuff for Pigs
All products with this active substance (9)
The same active substance in other countries
Spain
- AMOXICIVEN 100 mg/g POLVO PARA ADMINISTRACION EN AGUA DE BEBIDA
- AMOXOIL RETARD 150 mg/ml SUSPENSION INYECTABLE
- APSAMIX AMOXICILINA 200 mg/g PREMEZCLA MEDICAMENTOSA PARA PORCINO
- CITRAMOX LA 150 mg/ml SUSPENSION INYECTABLE PARA BOVINO Y PORCINO
- CLAMOXYL VETERINARIA L.A. 150 mg/ml SUSPENSION INYECTABLE
All products with this active substance (10)
Poland
- Amatib 800 mg/g proszek doustny dla świń i kur
- Amoksycylina Global Vet Health 500 mg/g, proszek do podania w wodzie do picia dla kur, indyków, kaczek i świń
- Amotaks, 200 mg, tabletki dla psów
- Amotaks, 40 mg, tabletki dla psów i kotów
- Amoxibactin vet 250 mg tabletki dla psów
All products with this active substance (31)